Evidence map›Paper›PMID 20600219›Full record

ArticleToxicology and applied pharmacology2010

Multiple protein kinase pathways mediate amplified IL-6 release by human lung fibroblasts co-exposed to nickel and TLR-2 agonist, MALP-2.

Fei Gao, Kelly A Brant, Rachel M Ward, Richard T Cattley, Aaron Barchowsky, James P Fabisiak

Abstract read
In one paragraph

Article in Toxicology and applied pharmacology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Fei GaoDepartment of Environmental & Occupational Health, Center for Free Radical and Antioxidant Health, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA 15219, USA.
Kelly A Brant
Rachel M Ward
Richard T Cattley
Aaron Barchowsky
James P Fabisiak
University of Pittsburgh · US

Funding

REGULATION OF TRANSCRIPTIONAL COMPETENCE BY CHROMIUMR01ES010638 · NIEHS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BARCHOWSKY, AARON · 2001 to 2005
$1.4M
Particulate Matter/Mycoplasma Stress InteractionsR01ES011986 · NIEHS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FABISIAK, JAMES P · 2005 to 2008
$1.1M
Synergistic activation of PTGS2 and CXCL8 by Ni and microbial stimuliF32ES015966 · NIEHS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BRANT, KELLY · 2007 to 2008
$101k
NIEHS NIH HHS F32 ES015966NIEHS NIH HHS F32-ES-015966NIEHS NIH HHS R01-ES-001986NIEHS NIH HHS R01 ES010638NIEHS NIH HHS R01 ES011986NIEHS NIH HHS R01-ES-10638
6 · The paper itself

Abstract

Microbial stimuli and atmospheric particulate matter (PM) interact to amplify the release of inflammatory and immune-modulating cytokines. The basis of this interaction, however, is not known. Cultured human lung fibroblasts (HLF) were used to determine whether various protein kinase pathways were involved in the release of IL-6 following combined exposure to the PM-derived metal, Ni, and M. fermentans-derived macrophage-activating lipopeptide 2 (MALP-2), a toll-like receptor 2 agonist. Synergistic release of IL-6 by MALP-2 and NiSO4 was obvious after 8h of co-stimulation and correlated with a late phase accumulation of IL-6 mRNA. Ni and MALP-2, alone or together, all led to rapid and transient phosphorylations of ERK(1/2) and JNK/SAPK of similar magnitude. p38 phosphorylation, however, was observed only after prolonged treatment of cells with both stimuli together. A constitutive level of PI3K-dependent Akt phosphorylation remained unchanged by Ni and/or MALP-2 exposure. IL-6 induced by Ni/MALP-2 co-exposure was partially dependent on activity of HIF-1alpha and COX-2 as shown by targeted knockdown using siRNA. IL-6 release in response to Ni/MALP-2 was partially sensitive to pharmacological inhibition of ERK(1/2), p38, and PI3K signaling. The protein kinase inhibitors had minimal or no effects on Ni/MALP-2-induced accumulation of HIF-1alpha protein, however, COX-2 expression and, more markedly PGE(2) production, were suppressed by LY294002, SB203580, and U0126. Thus, Ni/MALP-2 interactions involve multiple protein kinase pathways (ERK(1/2), p38, and PI3K) that modulate events downstream from the early accumulation of HIF-1alpha to promote IL-6 gene expression directly or secondarily, through COX-2-derived autocrine products like PGE(2).

Indexed as

Cells, CulturedCyclooxygenase 2Drug SynergismFibroblastsHumansHypoxia-Inducible Factor 1, alpha SubunitInterleukin-6LipopeptidesLungMitogen-Activated Protein KinasesNickelPhosphatidylinositol 3-KinasesProtein KinasesSignal TransductionToll-Like Receptor 2Cyclooxygenase 2HIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitInterleukin-6Lipopeptidesmacrophage stimulatory lipopeptide 2Mitogen-Activated Protein KinasesNickelPhosphatidylinositol 3-KinasesProtein KinasesToll-Like Receptor 2

Identifiers

PMID20600219
PMCPMC2919161
OpenAlexW2082009159

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.